pharma · Respiratory Syncytial Virus Infections · Asthma
MedImmune
MedImmune patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Gaithersburg, USA HQ
1987 Founded
896 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Gaithersburg, USA
- Founded
- 1987
- Employees
- 896
- Programs
- 9
- Drugs
- 7
- Patents
- 0
MedImmune patents
0 pharmaceutical patents indexed for MedImmune. 0 expire within 24 months.
MedImmune has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does MedImmune have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do MedImmune patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.